相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2
Jun Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis
Huan Gui et al.
IMMUNOBIOLOGY (2015)
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Caroline Turcotte et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
Rebecca H. Robinson et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice
Georg D. Duerr et al.
LIFE SCIENCES (2015)
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
Jie Wen et al.
NEUROPHARMACOLOGY (2015)
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
Natalia Malek et al.
NEURAL PLASTICITY (2015)
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients
A. J. Sanchez Lopez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Expression Analysis of CB2-GFP BAC Transgenic Mice
Anne-Caroline Schmoele et al.
PLOS ONE (2015)
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis
Jamal El Bakali et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
Valerio Chiurchiu et al.
ATHEROSCLEROSIS (2014)
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Shin Fukuda et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Regulatory role of the cannabinoid CB2 receptor in stress- induced neuroinflammation in mice
S. Zoppi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
Simone Tambaro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors
Valeria Gasperi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol
Marie-Chantal Larose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
Yannick Marchalant et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
J. Sardinha et al.
MEDIATORS OF INFLAMMATION (2014)
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis
Huan Gui et al.
RHEUMATOLOGY (2014)
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints
Eugene Krustev et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Updates in Reproduction Coming from the Endocannabinoid System
Rosaria Meccariello et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms
Thomas Michler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Distinct Modulation of Human Myeloid and Plasmacytoid Dendritic Cells by Anandamide in Multiple Sclerosis
Valerio Chiurchiu et al.
ANNALS OF NEUROLOGY (2013)
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Francesca Borrelli et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets
Maria Grazia Signorello et al.
BIOCHIMIE (2013)
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
Aurelien Tourteau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Bacterial lipopolyshaccaride inhibits CB2 receptor expression in human monocytic cells
Vedrana Reichenbach et al.
GUT (2013)
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV
Francois Chouinard et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists
Servio H. Ramirez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes
Julie T. Castaneda et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB2 receptor
Jean-Ha Baek et al.
JOURNAL OF NEUROSCIENCE METHODS (2013)
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
Carolina Costola-de-Souza et al.
PLOS ONE (2013)
Δ8-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: Involvement of cannabinoid receptor 2 and p38 MAPK
Satoshi Yamaori et al.
TOXICOLOGY (2013)
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression
Sabina Adhikary et al.
BLOOD (2012)
被撤回的出版物: Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide (Retracted article. See vol. 174, pg. 2609, 2017)
Stefania Merighi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice
Lamont Booker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors
Sandor Batkai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Human Platelets Express Authentic CB1 and CB2 Receptors
M. V. Catani et al.
CURRENT NEUROVASCULAR RESEARCH (2012)
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
Fabrizio Montecucco et al.
EUROPEAN HEART JOURNAL (2012)
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis
Jamal El Bakali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis
Natalia Battista et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway
Allisson Freire Bento et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells
Ravil R. Petrov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
Fernando Correa et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
Carol A. Rouzer et al.
CHEMICAL REVIEWS (2011)
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation
Antonia Sophocleous et al.
ENDOCRINOLOGY (2011)
The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas
Nazik Rayman et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity
Lin-Li Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
Mireille Alhouayek et al.
FASEB JOURNAL (2011)
CB2 Cannabinoid Receptor Targets Mitogenic Gi Protein-Cyclin D1 Axis in Osteoblasts
Orr Ofek et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Endocannabinoid 2-Arachidonoyl-Glycerol Activates Human Neutrophils: Critical Role of Its Hydrolysis and De Novo Leukotriene B4 Biosynthesis
Francois Chouinard et al.
JOURNAL OF IMMUNOLOGY (2011)
Modulation of Inflammatory Responses by a Cannabinoid-2-Selective Agonist after Spinal Cord Injury
Sabina Adhikary et al.
JOURNAL OF NEUROTRAUMA (2011)
Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons
Mayur Patil et al.
NEUROPHARMACOLOGY (2011)
Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
Florian Willecke et al.
PLOS ONE (2011)
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
Dianne J. M. Delsing et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2011)
Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
Courtney D. Netherland et al.
ATHEROSCLEROSIS (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Endocannabinoids and pregnancy
Anthony H. Taylor et al.
CLINICA CHIMICA ACTA (2010)
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
Yan Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
Sasidhar Murikinati et al.
FASEB JOURNAL (2010)
Anandamide Enhances IL-10 Production in Activated Microglia by Targeting CB2 Receptors: Roles of ERK1/2, JNK, and NF-κB
Fernando Correa et al.
GLIA (2010)
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle
Anthony H. Taylor et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
DETAILED CHARACTERISATION OF CB2 RECEPTOR PROTEIN EXPRESSION IN PERIPHERAL BLOOD IMMUNE CELLS FROM HEALTHY HUMAN VOLUNTEERS USING FLOW CYTOMETRY
E. S. Graham et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
Yan Zhao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages
Ming-xiu Hao et al.
JOURNAL OF LIPID RESEARCH (2010)
Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
Maria Teresa Cencioni et al.
PLOS ONE (2010)
Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment
William Insull
AMERICAN JOURNAL OF MEDICINE (2009)
Pyridine-3-carboxamides as novel CB(2) agonists for analgesia
William L. Mitchell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Characterization of human cannabinoid CB2 receptor coupled to chimeric Gαqi5 and Gαqo5 proteins
John Malysz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
Q. -R. Liu et al.
GENES BRAIN AND BEHAVIOR (2009)
Early Maternal Deprivation Induces Gender-Dependent Changes on the Expression of Hippocampal CB1 and CB2 Cannabinoid Receptors of Neonatal Rats
Juan Suarez et al.
HIPPOCAMPUS (2009)
Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis
Martin A. Storr et al.
INFLAMMATORY BOWEL DISEASES (2009)
Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB2 Agonist for the Treatment of Chronic Pain
Gerard M. P. Giblin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection
Catherine A. Newton et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Identification of Transcription Start Sites and Preferential Expression of Select CB2 Transcripts in Mouse and Human B Lymphocytes
Tracy A. Sherwood et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation
Edgar Alfonso Romero-Sandoval et al.
MOLECULAR PAIN (2009)
Localisation and Function of the Endocannabinoid System in the Human Ovary
Mona R. El-Talatini et al.
PLOS ONE (2009)
CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
Balazs Csoka et al.
PLOS ONE (2009)
The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis
Paola Grimaldi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
Fabrizio Montecucco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints
J. J. McDougall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs
L. Giannini et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
Juan Suarez et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation
Filomena Fezza et al.
JOURNAL OF LIPID RESEARCH (2008)
Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo
Serena Pasquini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Targeting endocannabinoid degradation protects against experimental colitis in mice:: involvement of CB1 and CB2 receptors
Martin A. Storr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation
Armen N. Akopian et al.
JOURNAL OF NEUROSCIENCE (2008)
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory T cells
Venkatesh L. Hegde et al.
MOLECULAR PHARMACOLOGY (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
Denise Richardson et al.
ARTHRITIS RESEARCH & THERAPY (2008)
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5:: Linkage to the CB2 receptor
Erinn S. Raborn et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes
Marisela Agudelo et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9-tetrahydrocannabinol
John P. Buchweitz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis
Akiko Shiratsuchi et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation
F. Comelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells
E. Gkoumassi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: A new role of Hsp-90 in migration signaling of a G protein-coupled receptor
Fang He et al.
MOLECULAR PHARMACOLOGY (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors
Toby K. Eisenstein et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Attenuation of allergic contact dermatitis through the endocannabinoid system
Meliha Karsak et al.
SCIENCE (2007)
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: Involvement of cannabinoid receptors
R. Bryan Rock et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells
Elda Del Giudice et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Discovery of 2-[(2,4-Dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]-4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain
Gerard M. P. Giblin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Katarzyna Maresz et al.
NATURE MEDICINE (2007)
Temporal variation in CB2R levels following T lymphocyte activation:: Evidence that cannabinoids modulate CXCL12-induced chemotaxis
Karen Coopman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice
Takashi Tanikawa et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice
Saori Oka et al.
JOURNAL OF IMMUNOLOGY (2006)
Tricyclic pyrazoles.: 4.: Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2′,4′-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide
Gabriele Murineddu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells
Monica Bari et al.
JOURNAL OF IMMUNOLOGY (2006)
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists
Clementina Manera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Formation of B and T cell subsets require the cannabinoid receptor CB2
David Ziring et al.
IMMUNOGENETICS (2006)
Jekyll and Hyde: Two faces of cannabinoid signaling in male and female fertility
Haibin Wang et al.
ENDOCRINE REVIEWS (2006)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Sharmistha Ghosh et al.
MOLECULAR IMMUNOLOGY (2006)
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
R Kurihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
JC Ashton et al.
NEUROSCIENCE LETTERS (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
E Eljaschewitsch et al.
NEURON (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: Comparison with other eosinophil chemoattractants
Seishi Kishimoto et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
SB Hanauer
INFLAMMATORY BOWEL DISEASES (2006)
Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages:: role of IL-10 and ERK1/2 kinase signaling
F Correa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes
M Gokoh et al.
FEBS LETTERS (2005)
Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures
S Ortega-Gutiérrez et al.
GLIA (2005)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells
AL Small-Howard et al.
BIOCHEMICAL JOURNAL (2005)
Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear
S Oka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells
M Gokoh et al.
BIOCHEMICAL JOURNAL (2005)
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells
S Kishimoto et al.
JOURNAL OF BIOCHEMISTRY (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain
JS Walczak et al.
NEUROSCIENCE (2005)
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells
S Kishimoto et al.
JOURNAL OF BIOCHEMISTRY (2004)
A novel synthetic, noripsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis
PF Sumariwalla et al.
ARTHRITIS AND RHEUMATISM (2004)
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN
C Di Filippo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status
N Rayman et al.
JOURNAL OF IMMUNOLOGY (2004)
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve
AV Derbenev et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein
GJM Maestroni
FASEB JOURNAL (2004)
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis:: Novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do et al.
JOURNAL OF IMMUNOLOGY (2004)
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
J Joseph et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
JD Leggett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
S Oka et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism
S Kishimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
A Klegeris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells
C Zoratti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
M Yuan et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Presence and regulation of the endocannabinoid system in human dendritic cells
I Matias et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Cloning and molecular characterization of the rat CB2 cannabinoid receptor
SM Brown et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-β
B Gardner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
SJ Carlisle et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells
Y Kobayashi et al.
JOURNAL OF BIOCHEMISTRY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
RA Ross et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor
MH Rhee et al.
FEBS LETTERS (2000)
分享论文
